- Drug name
- Dermatophagoides pteronyssinus
- dermatophagoides pteronyssinus
- Dermatophagoides pteronyssinus
- FDA ingredient codes (UNII)
Related records
Trials (22)
- A Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis
- A Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis
- Assessment of Sublingual Immunotherapy in Children Allergic to House Dust Mites
- Biological Standardization of Dermatophagoides Pteronyssinus Allergen Extract
- Comparative Evaluation of Safety and Immune Activity of New Immunotherapeutic Agents for HDM Allergic Rhinitis Patients
- Distinct Response of CD4+CD25+Foxp3+ and IL-10-secreting Type I T Regulatory Cells to Cluster Specific Immunotherapy in Allergic Rhinitis Children
- Efficacy and Safety Assessment of Beltavac® With Polymerized Extract of HDM
- Efficacy and Safety of Sublingual Immunotherapy for Allergic Rhinitis Due to House Dust Mites
- Efficacy and Safety Trial of Subcutaneous Immunotherapy in Mite Induced Asthma
- Efficacy of SLITone in House Dust Mite Allergic Patients
- Evaluate Measurement Instruments Relevance in Assessing Effectiveness of ACARIZAX® in House Dust Mite Allergic Rhinitis
- Imaging Study of the Lungs During an Allergic Asthma Attack
- Interest of Nasal Provocation Tests for Diagnosis of House Mites Allergic Rhinitis
- MAPS & ITEC Cohorts: 6-8 Years Follow-up
- Non-coding RNAs Analysis of Eosinophil Subtypes in Asthma
- Role of Extracellular Matrix in the Development of Airway Remodeling in Asthma
- Role of the Isomerase Pin-1 in the Development and Treatment of Asthma
- Safety and Efficacy of House Dust Mite Allergen Extract in the Treatment of Allergic Rhinoconjunctivitis
- Safety Study of Sublingual Immunotherapy Tablets of House Dust Mite Allergen Extracts
- Skin Responses and T Cell Immunology After House Dust Mite Exposure in Sensitized Atopic Dermatitis Patients